Skip to main content
Erschienen in: AIDS and Behavior 4/2017

20.08.2016 | Original Paper

The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis

verfasst von: Roman Shrestha, Damian Weikum, Michael Copenhaver, Frederick L. Altice

Erschienen in: AIDS and Behavior | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Prior research has widely recognized neurocognitive impairment (NCI), depression, and alcohol use disorders (AUDs) as important negative predictors of health-related quality of life (HRQoL) among people living with HIV (PLWH). No studies to date, however, have explored how these neuropsychological factors operate together and affect HRQoL. Incarcerated male PLWH (N = 301) meeting criteria for opioid dependence were recruited from Malaysia’s largest prison. Standardized scales for NCI, depression, alcohol use disorders (AUDs) and HRQoL were used to conduct a moderated mediation model to explore the extent to which depression mediated the relationship between NCI, HRQoL, and AUDs using an ordinary least squares regression-based path analytic framework. Results showed that increasing levels of NCI (B = −0.1773, p < 0.001) and depression (B = −0.6147, p < 0.001) were negatively associated with HRQoL. The effect of NCI on HRQoL was significantly (Sobel z = −3.5600, p < 0.001) mediated via depression (B = −0.1230, p < 0.001). Furthermore, the conditional indirect effect of NCI on HRQoL via depression for individuals with AUDs was significant (B = −0.9099, p = 0.0087), suggesting a moderated mediation effect. The findings disentangle the complex relationship using a moderated mediation model, demonstrating that increasing levels of NCI, which can be reduced with HIV treatment, negatively influenced HRQoL via depression for individuals with AUDs. This highlights the need for future interventions to target these complex interplay between neuropsychological factors in order to improve HRQoL among PLWH, particularly incarcerated PLWH with AUDs.
Literatur
1.
Zurück zum Zitat Dolan K, Wirtz A, Moazen B, Galvani AP, Ndeffo Mbah ML, Kinner S, et al. Global Burden of HIV, viral hepatitis and tuberculosis among prisoners and detainees. Lancet. 2016, (In press). Dolan K, Wirtz A, Moazen B, Galvani AP, Ndeffo Mbah ML, Kinner S, et al. Global Burden of HIV, viral hepatitis and tuberculosis among prisoners and detainees. Lancet. 2016, (In press).
3.
Zurück zum Zitat Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8:e81355.CrossRefPubMedPubMedCentral Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One. 2013;8:e81355.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Clayson DJ, Wild DJ, Quarterman P, Duprat-Lomon I, Kubin M, Coons SJ. A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials. Pharmacoeconomics. 2006;24:751–65.CrossRefPubMed Clayson DJ, Wild DJ, Quarterman P, Duprat-Lomon I, Kubin M, Coons SJ. A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials. Pharmacoeconomics. 2006;24:751–65.CrossRefPubMed
5.
Zurück zum Zitat Johnson M, Samarina A, Xi H, Valdez Ramalho Madruga J, Hocqueloux L, Loutfy M, et al. Barriers to access to care reported by women living with HIV across 27 countries. AIDS Care. 2015;27:1220–30.CrossRefPubMedPubMedCentral Johnson M, Samarina A, Xi H, Valdez Ramalho Madruga J, Hocqueloux L, Loutfy M, et al. Barriers to access to care reported by women living with HIV across 27 countries. AIDS Care. 2015;27:1220–30.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health. 2012;102:1516–26.CrossRefPubMedPubMedCentral Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health. 2012;102:1516–26.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Bazazi A, Crawford F, Zelenev A, Heimer R, Kamarulzaman A, Altice FL. HIV prevalence among people who inject drugs in Greater Kuala Lumpur recruited using respondent-driven sampling. AIDS Behav. 2015;19:2347–57.CrossRefPubMedPubMedCentral Bazazi A, Crawford F, Zelenev A, Heimer R, Kamarulzaman A, Altice FL. HIV prevalence among people who inject drugs in Greater Kuala Lumpur recruited using respondent-driven sampling. AIDS Behav. 2015;19:2347–57.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Zahari MM, Hwan Bae W, Zainal NZ, Habil H, Kamarulzaman A, Altice FL. Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia. Am J Drug Alcohol Abuse. 2010;36:31–8.CrossRefPubMedPubMedCentral Zahari MM, Hwan Bae W, Zainal NZ, Habil H, Kamarulzaman A, Altice FL. Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia. Am J Drug Alcohol Abuse. 2010;36:31–8.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend. 2011;116:151–7.CrossRefPubMedPubMedCentral Bachireddy C, Bazazi AR, Kavasery R, Govindasamy S, Kamarulzaman A, Altice FL. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention. Drug Alcohol Depend. 2011;116:151–7.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS. 2010;21:416–23.CrossRefPubMedPubMedCentral Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and correlates of community re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD AIDS. 2010;21:416–23.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372:1733–45.CrossRefPubMed Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372:1733–45.CrossRefPubMed
15.
Zurück zum Zitat Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376:355–66.CrossRefPubMed Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376:355–66.CrossRefPubMed
16.
Zurück zum Zitat Larney S, Dolan K. A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care? Eur Addict Res. 2009;15:107–12.CrossRefPubMed Larney S, Dolan K. A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care? Eur Addict Res. 2009;15:107–12.CrossRefPubMed
17.
Zurück zum Zitat Baillargeon J, Giordano TP, Rich JD, Wu ZH, Wells K, Pollock BH, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301:848–57.CrossRefPubMedPubMedCentral Baillargeon J, Giordano TP, Rich JD, Wu ZH, Wells K, Pollock BH, et al. Accessing antiretroviral therapy following release from prison. JAMA. 2009;301:848–57.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Festa L, Meucci O. Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism. Curr HIV Res. 2012;10:453–62.CrossRefPubMedPubMedCentral Festa L, Meucci O. Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism. Curr HIV Res. 2012;10:453–62.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Springer SA, Altice FL, Herme M, Di Paola A. Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community. Contemp Clin Trials. 2014;37:209–18.CrossRefPubMed Springer SA, Altice FL, Herme M, Di Paola A. Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community. Contemp Clin Trials. 2014;37:209–18.CrossRefPubMed
20.
Zurück zum Zitat Springer SA, Azar MM, Altice FL. HIV, alcohol dependence and the criminal justice system: a review and call for evidence-based treatment. Am J Drug Alcohol Abus. 2011;37:12–21.CrossRef Springer SA, Azar MM, Altice FL. HIV, alcohol dependence and the criminal justice system: a review and call for evidence-based treatment. Am J Drug Alcohol Abus. 2011;37:12–21.CrossRef
21.
Zurück zum Zitat Azbel L, Wickersham JA, Grishaev Y, Dvoryak S, Altice FL. Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community. PLoS ONE. 2013;8:e59643.CrossRefPubMedPubMedCentral Azbel L, Wickersham JA, Grishaev Y, Dvoryak S, Altice FL. Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community. PLoS ONE. 2013;8:e59643.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Scheyett A, Parker S, Golin C, White B, Davis CP, Wohl D. HIV-infected prison inmates: depression and implications for release back to communities. AIDS Behav. 2010;14:300–7.CrossRefPubMed Scheyett A, Parker S, Golin C, White B, Davis CP, Wohl D. HIV-infected prison inmates: depression and implications for release back to communities. AIDS Behav. 2010;14:300–7.CrossRefPubMed
23.
Zurück zum Zitat Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38:1754–60.CrossRefPubMed Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38:1754–60.CrossRefPubMed
24.
Zurück zum Zitat Stephenson BL, Wohl DA, Golin CE, Tien H-C, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120:84–8.CrossRefPubMedPubMedCentral Stephenson BL, Wohl DA, Golin CE, Tien H-C, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120:84–8.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Anand P, Springer SA, Copenhaver MM, Altice FL. Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav. 2010;14:1213–26.CrossRefPubMedPubMedCentral Anand P, Springer SA, Copenhaver MM, Altice FL. Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav. 2010;14:1213–26.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19–25.CrossRefPubMedPubMedCentral Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl 1):S19–25.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, et al. Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Arch Neurol. 1995;52:525–30.CrossRefPubMed Albert SM, Marder K, Dooneief G, Bell K, Sano M, Todak G, et al. Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Arch Neurol. 1995;52:525–30.CrossRefPubMed
28.
Zurück zum Zitat Mind Exchange Working Group. Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis. 2013;56:1004–17.CrossRef Mind Exchange Working Group. Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis. 2013;56:1004–17.CrossRef
29.
Zurück zum Zitat Villa G, Solida A, Moro E, Tavolozza M, Antinori A, De Luca A, et al. Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. Eur Neurol. 1996;36:125–33.CrossRefPubMed Villa G, Solida A, Moro E, Tavolozza M, Antinori A, De Luca A, et al. Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. Eur Neurol. 1996;36:125–33.CrossRefPubMed
30.
Zurück zum Zitat van Gorp WG, Baerwald JP, Ferrando SJ, McElhiney MC, Rabkin JG. The relationship between employment and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc. 1999;5:534–9.PubMed van Gorp WG, Baerwald JP, Ferrando SJ, McElhiney MC, Rabkin JG. The relationship between employment and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc. 1999;5:534–9.PubMed
31.
Zurück zum Zitat Stern Y, McDermott MP, Albert S, Palumbo D, Selnes OA, McArthur J, et al. Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol. 2001;58:473–9.CrossRefPubMed Stern Y, McDermott MP, Albert S, Palumbo D, Selnes OA, McArthur J, et al. Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol. 2001;58:473–9.CrossRefPubMed
32.
Zurück zum Zitat Bates ME, Bowden SC, Barry D. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp Clin Psychopharmacol. 2002;10:193–212.CrossRefPubMed Bates ME, Bowden SC, Barry D. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp Clin Psychopharmacol. 2002;10:193–212.CrossRefPubMed
33.
Zurück zum Zitat Shrestha R, Huedo-Medina TB, Copenhaver MM. Sex-related differences in self-reported neurocognitive impairment among high-risk cocaine users in methadone maintenance treatment program. Subst Abus. 2015;9:17–24. Shrestha R, Huedo-Medina TB, Copenhaver MM. Sex-related differences in self-reported neurocognitive impairment among high-risk cocaine users in methadone maintenance treatment program. Subst Abus. 2015;9:17–24.
34.
Zurück zum Zitat Kalichman SC, Simbayi LC, Kaufman M, Cain D, Jooste S. Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: systematic review of empirical findings. Prev Sci. 2007;8:141–51.CrossRefPubMed Kalichman SC, Simbayi LC, Kaufman M, Cain D, Jooste S. Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: systematic review of empirical findings. Prev Sci. 2007;8:141–51.CrossRefPubMed
35.
Zurück zum Zitat Ferro EG, Weikum D, Vagenas P, Copenhaver MM, Gonzales P, Peinado J, et al. Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru. AIDS Care. 2014;1–12. Ferro EG, Weikum D, Vagenas P, Copenhaver MM, Gonzales P, Peinado J, et al. Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru. AIDS Care. 2014;1–12.
36.
Zurück zum Zitat Weikum D, Ferro EG, Shrestha R, Vagenas P, Copenhaver MM, Spudich S, et al. Neurocognitive impairment negatively influences antiretroviral medication adherence among men who have sex with men in Peru. AIDS & Behavior. 2016 (Under review). Weikum D, Ferro EG, Shrestha R, Vagenas P, Copenhaver MM, Spudich S, et al. Neurocognitive impairment negatively influences antiretroviral medication adherence among men who have sex with men in Peru. AIDS & Behavior. 2016 (Under review).
37.
Zurück zum Zitat Huedo-Medina TB, Shrestha R, Copenhaver M. Modeling a theory-based approach to examine the influence of neurocognitive impairment on HIV risk reduction behaviors among drug users in treatment. AIDS and Behavior. 2016;1–12. Huedo-Medina TB, Shrestha R, Copenhaver M. Modeling a theory-based approach to examine the influence of neurocognitive impairment on HIV risk reduction behaviors among drug users in treatment. AIDS and Behavior. 2016;1–12.
38.
Zurück zum Zitat Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–8.CrossRefPubMed Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721–8.CrossRefPubMed
39.
Zurück zum Zitat Jin H, Hampton Atkinson J, Yu X, Heaton RK, Shi C, Marcotte TP, et al. Depression and suicidality in HIV/AIDS in China. J Affect Disord. 2006;94:269–75.CrossRefPubMed Jin H, Hampton Atkinson J, Yu X, Heaton RK, Shi C, Marcotte TP, et al. Depression and suicidality in HIV/AIDS in China. J Affect Disord. 2006;94:269–75.CrossRefPubMed
40.
Zurück zum Zitat Kagee A, Martin L. Symptoms of depression and anxiety among a sample of South African patients living with HIV. AIDS Care. 2010;22:159–65.CrossRefPubMed Kagee A, Martin L. Symptoms of depression and anxiety among a sample of South African patients living with HIV. AIDS Care. 2010;22:159–65.CrossRefPubMed
41.
Zurück zum Zitat Dal-Bo MJ, Manoel AL, Filho AO, Silva BQ, Cardoso YS, Cortez J, et al. Depressive symptoms and associated factors among people living with HIV/AIDS. J Int Assoc Provid AIDS Care. 2015;14:136–40.CrossRefPubMed Dal-Bo MJ, Manoel AL, Filho AO, Silva BQ, Cardoso YS, Cortez J, et al. Depressive symptoms and associated factors among people living with HIV/AIDS. J Int Assoc Provid AIDS Care. 2015;14:136–40.CrossRefPubMed
42.
Zurück zum Zitat Tate D, Paul RH, Flanigan TP, Tashima K, Nash J, Adair C, et al. The impact of apathy and depression on quality of life in patients infected with HIV. AIDS Patient Care STDS. 2003;17:115–20.CrossRefPubMed Tate D, Paul RH, Flanigan TP, Tashima K, Nash J, Adair C, et al. The impact of apathy and depression on quality of life in patients infected with HIV. AIDS Patient Care STDS. 2003;17:115–20.CrossRefPubMed
43.
Zurück zum Zitat Jia H, Uphold CR, Wu S, Chen GJ, Duncan PW. Predictors of changes in health-related quality of life among men with HIV infection in the HAART era. AIDS Patient Care STDS. 2005;19:395–405.CrossRefPubMed Jia H, Uphold CR, Wu S, Chen GJ, Duncan PW. Predictors of changes in health-related quality of life among men with HIV infection in the HAART era. AIDS Patient Care STDS. 2005;19:395–405.CrossRefPubMed
44.
Zurück zum Zitat Charles B, Jeyaseelan L, Pandian AK, Sam AE, Thenmozhi M, Jayaseelan V. Association between stigma, depression and quality of life of people living with HIV/AIDS (PLHA) in South India–a community based cross sectional study. BMC Public Health. 2012;12:463.CrossRefPubMedPubMedCentral Charles B, Jeyaseelan L, Pandian AK, Sam AE, Thenmozhi M, Jayaseelan V. Association between stigma, depression and quality of life of people living with HIV/AIDS (PLHA) in South India–a community based cross sectional study. BMC Public Health. 2012;12:463.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, et al. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS. 2004;15:254–9.CrossRefPubMed Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, et al. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS. 2004;15:254–9.CrossRefPubMed
46.
Zurück zum Zitat Osowiecki DM, Cohen RA, Morrow KM, Paul RH, Carpenter CCJ, Flanigan T, et al. Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. AIDS. 2000;14:1327–32.CrossRefPubMed Osowiecki DM, Cohen RA, Morrow KM, Paul RH, Carpenter CCJ, Flanigan T, et al. Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. AIDS. 2000;14:1327–32.CrossRefPubMed
47.
Zurück zum Zitat Adewuya AO, Afolabi MO, Ola BA, Ogundele OA, Ajibare AO, Oladipo BF, et al. Relationship between depression and quality of life in persons with HIV infection in Nigeria. Int J Psychiatry Med. 2008;38:43–51.CrossRefPubMed Adewuya AO, Afolabi MO, Ola BA, Ogundele OA, Ajibare AO, Oladipo BF, et al. Relationship between depression and quality of life in persons with HIV infection in Nigeria. Int J Psychiatry Med. 2008;38:43–51.CrossRefPubMed
48.
Zurück zum Zitat Rosenbloom MJ, Sullivan EV, Sassoon SA, O’reilly A, Fama R, Kemper CA, et al. Alcoholism, HIV infection, and their comorbidity: factors affecting self-rated health-related quality of life. J Stud Alcohol Drugs. 2007;68:115–25.CrossRefPubMed Rosenbloom MJ, Sullivan EV, Sassoon SA, O’reilly A, Fama R, Kemper CA, et al. Alcoholism, HIV infection, and their comorbidity: factors affecting self-rated health-related quality of life. J Stud Alcohol Drugs. 2007;68:115–25.CrossRefPubMed
49.
Zurück zum Zitat Tran BX, Nguyen LT, Do CD, Nguyen QL, Maher RM. Associations between alcohol use disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS. BMC Public Health. 2014;14:1–7.CrossRef Tran BX, Nguyen LT, Do CD, Nguyen QL, Maher RM. Associations between alcohol use disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS. BMC Public Health. 2014;14:1–7.CrossRef
50.
Zurück zum Zitat Wickersham JA, Zahari MM, Azar MM, Kamarulzaman A, Altice FL. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug Alcohol Depend. 2013;132:378–82.CrossRefPubMedPubMedCentral Wickersham JA, Zahari MM, Azar MM, Kamarulzaman A, Altice FL. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug Alcohol Depend. 2013;132:378–82.CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Wickersham JA, Marcus R, Kamarulzaman A, Zahari MM, Altice FL. Implementing methadone maintenance treatment in prisons in Malaysia. Bull World Health Organ. 2013;91:124–9.CrossRefPubMedPubMedCentral Wickersham JA, Marcus R, Kamarulzaman A, Zahari MM, Altice FL. Implementing methadone maintenance treatment in prisons in Malaysia. Bull World Health Organ. 2013;91:124–9.CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health psychol. 2003;22:223–8.CrossRefPubMed Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health psychol. 2003;22:223–8.CrossRefPubMed
53.
Zurück zum Zitat Brislin RW. Back-translation for cross-cultural research. J Cross-Cult Psychol. 1970;1:185–216.CrossRef Brislin RW. Back-translation for cross-cultural research. J Cross-Cult Psychol. 1970;1:185–216.CrossRef
54.
Zurück zum Zitat Shrestha R, Karki P, Heudo-Medina T, Copenhaver M. Treatment engagement moderates the effect of neurocognitive impairment on antiretroviral therapy adherence among HIV-infected drug users in treatment. J Assoc Nurses AIDS Care. 2016, (Under review). Shrestha R, Karki P, Heudo-Medina T, Copenhaver M. Treatment engagement moderates the effect of neurocognitive impairment on antiretroviral therapy adherence among HIV-infected drug users in treatment. J Assoc Nurses AIDS Care. 2016, (Under review).
55.
Zurück zum Zitat Copenhaver M, Shrestha R, Wickersham JA, Weikum D, Altice FL. An exploratory factor analysis of a brief self-report scale to detect neurocognitive impairment among participants enrolled in methadone maintenance therapy. J Subst Abus Treat. 2016. Copenhaver M, Shrestha R, Wickersham JA, Weikum D, Altice FL. An exploratory factor analysis of a brief self-report scale to detect neurocognitive impairment among participants enrolled in methadone maintenance therapy. J Subst Abus Treat. 2016.
56.
Zurück zum Zitat Shrestha R, Weikum D, Copenhaver M, Altice F. A self-report measure to detect neurocognitive impairment among incarcerated people living with HIV in Malaysian context: an exploratory factor analysis. PLoS One. 2016, (Under review). Shrestha R, Weikum D, Copenhaver M, Altice F. A self-report measure to detect neurocognitive impairment among incarcerated people living with HIV in Malaysian context: an exploratory factor analysis. PLoS One. 2016, (Under review).
57.
Zurück zum Zitat Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef
58.
Zurück zum Zitat Cook JA, Cohen MH, Burke J, Grey D, Anastos K, Kirstein L, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr. 2002;30:401–9.CrossRefPubMed Cook JA, Cohen MH, Burke J, Grey D, Anastos K, Kirstein L, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr. 2002;30:401–9.CrossRefPubMed
59.
Zurück zum Zitat Low-Beer S, Chan K, Yip B, Wood E, Montaner JS, O’Shaughnessy MV, et al. Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr. 2000;23:295–301.CrossRefPubMed Low-Beer S, Chan K, Yip B, Wood E, Montaner JS, O’Shaughnessy MV, et al. Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr. 2000;23:295–301.CrossRefPubMed
60.
Zurück zum Zitat Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The alcohol use disorders identification test: guidelines for use in primary care. 2001; 2. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. The alcohol use disorders identification test: guidelines for use in primary care. 2001; 2.
61.
Zurück zum Zitat Hays RD, Sherbourne CD, Mazel RM. The rand 36-item health survey 1.0. Health Econ. 1993;2:217–27.CrossRefPubMed Hays RD, Sherbourne CD, Mazel RM. The rand 36-item health survey 1.0. Health Econ. 1993;2:217–27.CrossRefPubMed
62.
Zurück zum Zitat Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173.CrossRefPubMed Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173.CrossRefPubMed
63.
Zurück zum Zitat Oguntibeju OO. Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV/AIDS (Auckland, N.Z.). 2012;4:117–24. Oguntibeju OO. Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV/AIDS (Auckland, N.Z.). 2012;4:117–24.
64.
Zurück zum Zitat McInerney PA, Ncama BP, Wantland D, Bhengu BR, McGibbon C, Davis SM, et al. Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa. Nursing & Health Sciences. 2008;10:266–72.CrossRef McInerney PA, Ncama BP, Wantland D, Bhengu BR, McGibbon C, Davis SM, et al. Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa. Nursing & Health Sciences. 2008;10:266–72.CrossRef
65.
Zurück zum Zitat Safren SA, Hendriksen ES, Smeaton L, Celentano DD, Hosseinipour MC, Barnett R, et al. Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world. AIDS Behav. 2012;16:266–77.CrossRefPubMedPubMedCentral Safren SA, Hendriksen ES, Smeaton L, Celentano DD, Hosseinipour MC, Barnett R, et al. Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world. AIDS Behav. 2012;16:266–77.CrossRefPubMedPubMedCentral
66.
Zurück zum Zitat Igumbor J, Stewart A, Holzemer W. Comparison of the health-related quality of life, CD4 count and viral load of AIDS patients and people with HIV who have been on treatment for 12 months in rural South Africa. SAHARA J. 2013;10:25–31.PubMedPubMedCentral Igumbor J, Stewart A, Holzemer W. Comparison of the health-related quality of life, CD4 count and viral load of AIDS patients and people with HIV who have been on treatment for 12 months in rural South Africa. SAHARA J. 2013;10:25–31.PubMedPubMedCentral
67.
Zurück zum Zitat Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. Guilford Press; 2013. Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. Guilford Press; 2013.
68.
Zurück zum Zitat Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol. 1982;13:290–312.CrossRef Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol. 1982;13:290–312.CrossRef
69.
Zurück zum Zitat Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior research methods. 2008;40:879–91.CrossRefPubMed Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior research methods. 2008;40:879–91.CrossRefPubMed
70.
Zurück zum Zitat MacKinnon DP, Lockwood CM, Williams J. Confidence limits for the indirect effect: distribution of the product and resampling methods. Multivar Behav Res. 2004;39:99.CrossRef MacKinnon DP, Lockwood CM, Williams J. Confidence limits for the indirect effect: distribution of the product and resampling methods. Multivar Behav Res. 2004;39:99.CrossRef
71.
Zurück zum Zitat Bollen KA, Stine R. Direct and indirect effects: classical and bootstrap estimates of variability. Sociol Methodol. 1990;20:15–140.CrossRef Bollen KA, Stine R. Direct and indirect effects: classical and bootstrap estimates of variability. Sociol Methodol. 1990;20:15–140.CrossRef
72.
Zurück zum Zitat Hayes AF. An index and test of linear moderated mediation. Multivar Behav Res. 2015;50:1–22.CrossRef Hayes AF. An index and test of linear moderated mediation. Multivar Behav Res. 2015;50:1–22.CrossRef
73.
Zurück zum Zitat Preacher KJ, Rucker DD, Hayes AF. Addressing moderated mediation hypotheses: theory, methods, and prescriptions. Multivar Behav Res. 2007;42:185–227.CrossRef Preacher KJ, Rucker DD, Hayes AF. Addressing moderated mediation hypotheses: theory, methods, and prescriptions. Multivar Behav Res. 2007;42:185–227.CrossRef
74.
Zurück zum Zitat Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, et al. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS. 2004;15:254–9.CrossRefPubMed Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, et al. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS. 2004;15:254–9.CrossRefPubMed
75.
Zurück zum Zitat Rodriguez-Penney AT, Iudicello JE, Riggs PK, Doyle K, Ellis RJ, Letendre SL, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS patient care STDs. 2013;27:5–16.CrossRefPubMedPubMedCentral Rodriguez-Penney AT, Iudicello JE, Riggs PK, Doyle K, Ellis RJ, Letendre SL, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS patient care STDs. 2013;27:5–16.CrossRefPubMedPubMedCentral
76.
Zurück zum Zitat Mitchell AJ, Kemp S, Benito-León J, Reuber M. The influence of cognitive impairment on health-related quality of life in neurological disease. Acta Neuropsychiatrica. 2010;22:2–13.CrossRef Mitchell AJ, Kemp S, Benito-León J, Reuber M. The influence of cognitive impairment on health-related quality of life in neurological disease. Acta Neuropsychiatrica. 2010;22:2–13.CrossRef
77.
Zurück zum Zitat Sherbourne CD, Hays RD, Fleishman JA, Vitiello B, Magruder KM, Bing EG, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248–54.CrossRefPubMed Sherbourne CD, Hays RD, Fleishman JA, Vitiello B, Magruder KM, Bing EG, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248–54.CrossRefPubMed
78.
Zurück zum Zitat Korthuis PT, Zephyrin LC, Fleishman JA, Saha S, Josephs JS, McGrath MM, et al. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDs. 2008;22:859–67.CrossRefPubMedPubMedCentral Korthuis PT, Zephyrin LC, Fleishman JA, Saha S, Josephs JS, McGrath MM, et al. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDs. 2008;22:859–67.CrossRefPubMedPubMedCentral
79.
Zurück zum Zitat Nakasujja N, R Skolasky L, Musisi S, Allebeck P, Robertson K, Ronald A, et al. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry. 2010;10:1–7.CrossRef Nakasujja N, R Skolasky L, Musisi S, Allebeck P, Robertson K, Ronald A, et al. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry. 2010;10:1–7.CrossRef
80.
Zurück zum Zitat Bhatia R, Hartman C, Kallen MA, Graham J, Giordano TP. Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the Steps Study. AIDS Behav. 2011;15:1161–70.CrossRefPubMedPubMedCentral Bhatia R, Hartman C, Kallen MA, Graham J, Giordano TP. Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the Steps Study. AIDS Behav. 2011;15:1161–70.CrossRefPubMedPubMedCentral
81.
Zurück zum Zitat Althoff AL, Zelenev A, Meyer JP, Fu J, Brown SE, Vagenas P, et al. Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav. 2013;17(Suppl 2):S156–70.CrossRefPubMed Althoff AL, Zelenev A, Meyer JP, Fu J, Brown SE, Vagenas P, et al. Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav. 2013;17(Suppl 2):S156–70.CrossRefPubMed
82.
Zurück zum Zitat Meyer JP, Cepeda J, Springer SA, Wu J, Trestman RL, Altice FL. HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study. Lancet HIV. 2014;1:e77–84.CrossRefPubMedPubMedCentral Meyer JP, Cepeda J, Springer SA, Wu J, Trestman RL, Altice FL. HIV in people reincarcerated in Connecticut prisons and jails: an observational cohort study. Lancet HIV. 2014;1:e77–84.CrossRefPubMedPubMedCentral
83.
Zurück zum Zitat Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med. 2014;174:721–9.CrossRefPubMedPubMedCentral Meyer JP, Cepeda J, Wu J, Trestman RL, Altice FL, Springer SA. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med. 2014;174:721–9.CrossRefPubMedPubMedCentral
84.
Zurück zum Zitat Springer SA, Spaulding A, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53:469–79.CrossRefPubMedPubMedCentral Springer SA, Spaulding A, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53:469–79.CrossRefPubMedPubMedCentral
Metadaten
Titel
The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis
verfasst von
Roman Shrestha
Damian Weikum
Michael Copenhaver
Frederick L. Altice
Publikationsdatum
20.08.2016
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 4/2017
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1526-3

Weitere Artikel der Ausgabe 4/2017

AIDS and Behavior 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.